⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Official Title: Clinical Characteristics, Outcomes and Quality of Life in Patients With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab After Prior Chemotherapy as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Study ID: NCT04936399

Interventions

Nivolumab

Study Description

Brief Summary: This purpose of this observational study is to review medical chart and patient survey data collection within an early access to medicines scheme (EAMS) program. Participant who are eligible, provide consent and enroll into the squamous cell oesophageal cancer EAMS to receive Nivolumab will be included in this study.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Local Institution - 0006, Truro, Cornwall, United Kingdom

Local Institution, London, Greater London, United Kingdom

Local Institution, Maidstone, Kent, United Kingdom

Local Institution, Glasgow, Lanarkshire, United Kingdom

Local Institution, Grimsby, Lincolnshire, United Kingdom

Local Institution, Edinburgh, Scotland, United Kingdom

Local Institution, Birmingham, West Midlands, United Kingdom

Local Institution, Leeds, West Yorkshire, United Kingdom

Local Institution, Basingstoke, , United Kingdom

Local Institution, Bebington, , United Kingdom

Local Institution, Belfast, , United Kingdom

Local Institution, Birmingham, , United Kingdom

Local Institution, Blackburn, , United Kingdom

Local Institution - 0037, Bristol, , United Kingdom

Local Institution, Cambridge, , United Kingdom

Local Institution, Cardiff, , United Kingdom

Local Institution, Cottingham, , United Kingdom

Local Institution, Coventry, , United Kingdom

Local Institution, Derby, , United Kingdom

Local Institution, Devon, , United Kingdom

Local Institution, Dundee, , United Kingdom

Local Institution, Headington, , United Kingdom

Local Institution, Lancaster, , United Kingdom

Local Institution, London, , United Kingdom

Local Institution, London, , United Kingdom

Local Institution, London, , United Kingdom

Local Institution, Manchester, , United Kingdom

Local Institution, Melrose, , United Kingdom

Local Institution, Northwood, , United Kingdom

Local Institution, Nottingham, , United Kingdom

Local Institution, Pembrokeshire, , United Kingdom

Local Institution, Preston, , United Kingdom

Local Institution, Surrey, , United Kingdom

Local Institution, Surrey, , United Kingdom

Local Institution, Taunton, , United Kingdom

Local Institution, Walsall, , United Kingdom

Contact Details

Name: Bristol-Myers Squibb

Affiliation: Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: